Agilent offers new flow cytometers

By The Science Advisory Board staff writers

September 17, 2020 -- Agilent Technologies has launched a new product offering, the Agilent NovoCyte Penteon, a flow cytometer with five lasers and up to 30 fluorescence channels.

The product provides high sensitivity, resolution, speed, and flexibility in the analysis of samples. It has a dynamic range of 7.2 log and fully automated compensation features which enable users to detect dim and bright signals simultaneously.

The resolution of the NovoCyte Penteon can discern objects in the range of 100 nm. Partnered with NovoExpress software package, the process (acquisition, analysis, and reporting) can be fully automated.

Agilent expands molecule manufacturing capacity
Agilent Technologies said that it's expanding its Frederick, CO-based production facility to more than double its current capacity for developing the...
Agilent unveils new handheld raw material ID system
Agilent Technologies has launched Vaya Raman, a handheld raw material identity verification system for pharmaceutical manufacturers.
Agilent launches new microarrays for cytogenetic testing
Agilent Technologies has unveiled three new microarrays to support pre- and postnatal research by cytogenetic laboratories.
Agilent to fund biotherapy incubator in India
Agilent Technologies has announced a partnership with the Indian Institute of Technology Delhi to advance biotherapeutic research in the country.
Agilent unveils SureSelect DNA kit
Agilent Technologies has debuted SureSelect XT HS2, a DNA kit designed to help laboratories prepare DNA sequencing libraries for cancer and genetics research.

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Conferences
Festival of Genomics & Biodata
January 28-29, 2021
London, Greater London United Kingdom
Lab of the Future USA
May 11-12, 2021
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter